Stocks and InvestingStocks and Investing
Wed, September 27, 2023
Tue, September 26, 2023
Mon, September 25, 2023
Fri, September 22, 2023

Raghuram Selvaraju Reiterated (TRDA) at Strong Buy and Held Target at $25 on, Sep 22nd, 2023


Published on 2024-10-28 06:31:54 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Entrada Therapeutics, Inc." (TRDA) at Strong Buy and Held Target at $25 on, Sep 22nd, 2023.

Raghuram, nor any peers, have made any analyst calls on TRDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30